Weeks after being arrested on charges of security fraud, Martin Shkreli, a Wall Street tycoon who gained notoriety for buying the rights of drugs and then dramatically raising their prices, received a subpoena to appear before a Congressional committee investigating price gouging in the pharmaceutical industry.
The House Committee on Oversight and Government Reform delivered a subpoena to Shkreli's attorneys, demanding his presence at a hearing on Tuesday, the New York Times reports.
The brash executive responded to the subpoena with characteristic nonchalance on Twitter:
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Critical BenefitsPRO information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
- Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events
- Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
Already have an account? Sign In
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.